Ensuring access to generic antiretroviral medicines in low- and middle-income countries

The recent scale-up of the number of people living with HIV accessing antiretroviral therapy can be linked to the increased availability of generic antiretroviral medicines. Given that people living with HIV will need life-long access to such medicines, there is a need to scale up the research and development, production and distribution of generic antiretroviral medicines that are both effective and affordable.